TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL June 11, 2014
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive CCOP 2 Under Way After Bitter Recompetition Cancer Control Protocols Being Review; PLs, Affiliates Listed February 19, 1988